![](/img/cover-not-exists.png)
The PARP inhibitor olaparib enhances the cytotoxicity of combined gemcitabine, busulfan and melphalan in lymphoma cells
Valdez, Benigno C., Li, Yang, Murray, David, Liu, Yan, Nieto, Yago, Champlin, Richard E., Andersson, Borje S.Language:
english
Journal:
Leukemia & Lymphoma
DOI:
10.1080/10428194.2017.1306647
Date:
April, 2017
File:
PDF, 1.72 MB
english, 2017